Anrs, Emerging Infectious Diseases
Clinical trials sponsored by Anrs, Emerging Infectious Diseases, explained in plain language.
-
Ebola shield: can a Vaccine-Antibody duo stop the virus?
Prevention Not yet recruitingThis study tests whether giving the Ervebo vaccine together with Inmazeb antibodies can safely prevent Ebola in healthy adults. The vaccine works slowly, while antibodies act fast, so researchers want to see if they interfere with each other. About 132 volunteers will receive dif…
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated May 17, 2026 02:21 UTC
-
Ebola breakthrough? new trial aims to stop virus after exposure
Prevention Not yet recruitingThis study tests whether giving a combination of a vaccine (Ervebo) and an antibody drug (Inmazeb) right after exposure to Ebola can prevent the disease better than the vaccine alone. It involves 160 people who have had close contact with an Ebola patient, such as touching their …
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated May 14, 2026 12:06 UTC
-
New study to uncover how HIV affects aging in west africa
Knowledge-focused Not yet recruitingThis study looks at frailty and other age-related health problems in 600 older adults (60+) in Burkina Faso, Côte d'Ivoire, and Togo. Half have HIV, half do not. Researchers want to see if HIV speeds up aging and find better ways to screen for and manage these issues. The goal is…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated May 17, 2026 02:17 UTC
-
4000 kids to be tracked for hidden brain infection in cambodia
Knowledge-focused Not yet recruitingThis study aims to find out how common Japanese Encephalitis (JE) virus is among children in Cambodia, both in those who are healthy and those hospitalized with fever and brain symptoms. Researchers will follow 4000 children aged 2-14, testing blood for signs of the virus. The go…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Massive french study to track virus risks in pregnancy for 7 years
Knowledge-focused Not yet recruitingThis study will follow over 5,000 pregnant women with HIV, hepatitis B, hepatitis C, or arbovirus infections, along with their children, for up to 7 years. Researchers aim to learn how often the virus passes from mother to child and how infections and treatments affect pregnancy,…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC